C4 Therapeutics, Inc

c4therapeutics.com

C4 Therapeutics (NASDAQ: CCCC) is a clinical-stage biopharmaceutical company focused on targeted protein degradation as a therapeutic approach. The company does not generate product revenue. Its revenue model relies on collaboration agreements, milestones, and research funding from pharmaceutical partners rather than commercial drug sales. The available filing excerpts from the 10-K filed 2026-02-26 (accession 000162828026012000) do not contain sufficient detail to characterize specific programs, pipeline assets, partnership terms, financial results, leadership, founding year, headquarters, or competitive positioning. No specific revenue figures, customer concentrations, geographic breakdowns, or named competitors are supported by the excerpts provided. A complete business description requires access to the full filing body.